Why the study?
Does metabolic surgery reduce major adverse cardiovascular events in severely obese patients with previous myocardial infarction?
Does metabolic surgery reduce major adverse cardiovascular events in severely obese patients with previous myocardial infarction?
Metabolic surgery is associated with improved cardiovascular outcomes in severely obese patients with a history of myocardial infarction.
In severely obese patients with previous MI, metabolic surgery is associated with a low risk for serious complications, lower risk of major adverse cardiovascular events, death, new MI, and new onset heart failure. These findings need to be confirmed in a randomized, controlled trial.
No takes yet. Share an insight, caveat, or question.
Näslund et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: